Do 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline data support the conclusion of threshold carcinogenic effects?
From MaRDI portal
Publication:954731
DOI10.1007/S00477-007-0150-1zbMATH Open1149.92316OpenAlexW2028582992MaRDI QIDQ954731FDOQ954731
Authors: Chao Chen, Kate Z. Guyton 
Publication date: 17 November 2008
Published in: Stochastic Environmental Research and Risk Assessment (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s00477-007-0150-1
Recommendations
- Estimating Carcinogenic Potency from a Rodent Tumorigenicity Experiment
- scientific article; zbMATH DE number 3924570
- Calculation of Carcinogenic Potency from Long-Term Animal Carcinogenesis Experiments
- QSAR analysis of 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines exhibiting anticancer activity by optimal SMILES-based descriptors
- Effects of Treatment-Induced Mortality and Tumor-Induced Mortality on Tests for Carcinogenicity in Small Samples
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
This page was built for publication: Do 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline data support the conclusion of threshold carcinogenic effects?
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q954731)
